Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Maine Medical Center Research Institute.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Indiana University School of Medicine
Information provided by:
Maine Medical Center Research Institute
ClinicalTrials.gov Identifier:
NCT01255943
First received: December 6, 2010
Last updated: December 7, 2010
Last verified: July 2010

December 6, 2010
December 7, 2010
July 2010
September 2011   (final data collection date for primary outcome measure)
Incidence of bloodstream infections [ Time Frame: 14 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01255943 on ClinicalTrials.gov Archive Site
Incidence of MRSA infections [ Time Frame: 14 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
Testing Spread and Implementation of Novel MRSA-Reducing Practices

The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery and action" dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

prevalent hemodialysis patients at two outpatient dialysis units

  • Blood Stream Infections
  • MRSA Infections
Behavioral: healthcare staff processes for infection prevention
Toyota lean and positive deviance discovery and action dialogues to facilitate process improvement
prevalent hemodialysis patients
These patients are observed in two outpatient dialysis units with a combined census of approximately 175 patients
Intervention: Behavioral: healthcare staff processes for infection prevention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
175
October 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria: all hemodialysis patients at two outpatient dialysis units

Exclusion Criteria:peritoneal dialysis patients

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01255943
HHSA290200600013
Yes
Mark G. Parker, Maine Medical Center Research Institute
Maine Medical Center Research Institute
  • Agency for Healthcare Research and Quality (AHRQ)
  • Indiana University School of Medicine
Principal Investigator: Mark G Parker, MD Maine Medical Center Research Institute
Maine Medical Center Research Institute
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP